Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-049419
Filing Date
2021-04-12
Accepted
2021-04-12 18:56:55
Documents
2
Period of Report
2021-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2112624d5_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2112624d5_3seq1.xml 3 1621
2 EXHIBIT 24.1 tm2112624d5_ex24-1.htm EX-24.1 10010
  Complete submission text file 0001104659-21-049419.txt   13051
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYEGATE PHARMACEUTICALS INC. 271 WAVERLY OAKS RD., STE 108 WALTHAM MA 02452
Business Address
Shapiro Aron (Reporting) CIK: 0001855207 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 21821687